Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. on March 21, 2025, reporting events occurring on March 17, 2025. The filing addresses a material amendment to a Standby Equity Purchase Agreement (SEPA) and a convertible note previously entered into with YA II PN, Ltd ("Yorkville") on March 13, 2024.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data points relate to the Yorkville Transaction Documents:
- Convertible Note Principal: $3,150,000.
- SEPA Capacity: Up to $10.0 million of Class A common stock.
- Equity Issuance: 100,000 shares of Class A common stock issued to Yorkville as consideration for the agreement extension.
- Warrant Exercise Price: $11.50 per share (for existing warrants).
Material Changes and Agreements
On March 17, 2025, the Company entered into a Letter Agreement with Yorkville resulting in the following material changes:
- Maturity Extension: The maturity date of the $3,150,000 convertible note was extended from March 13, 2025, to May 12, 2025.
- Forbearance: Yorkville agreed not to declare an event of default under the Yorkville Transaction Documents until May 12, 2025.
- Consideration: In exchange for the extension and forbearance, the Company issued 100,000 shares of Class A common stock to Yorkville.
- Registration Rights: The newly issued shares carry piggyback registration rights, allowing their resale to be included in future registration statements filed by the Company.
Outlook, Risks, and Unusual Items
The filing indicates that the shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933. The document explicitly states that the offer and sale have not been registered and that the shares may not be offered or sold in the United States absent registration or an applicable exemption. The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclaimers regarding the unregistered nature of the securities.
Key Facts for Investor Verification
- Verify the current status of the $3,150,000 convertible note and the Company's ability to repay or convert it by the new May 12, 2025 maturity date.
- Confirm the dilution impact of the 100,000 shares issued to Yorkville on existing shareholders.
- Review the full text of the Letter Agreement (Exhibit 10.1) for any additional covenants or conditions attached to the forbearance.
- Monitor the Company's cash position to ensure it can meet obligations under the SEPA and the extended note without triggering a default.